147 related articles for article (PubMed ID: 30623224)
1. [New molecular pathological strategies for malignant iris tumors].
Kakkassery V; Jünemann AM; Scheef BO; Grisanti S; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):324-331. PubMed ID: 30623224
[TBL] [Abstract][Full Text] [Related]
2. Genetic findings in treatment-naïve and proton-beam-radiated iris melanomas.
Krishna Y; Kalirai H; Thornton S; Damato BE; Heimann H; Coupland SE
Br J Ophthalmol; 2016 Jul; 100(7):1012-1016. PubMed ID: 27098748
[TBL] [Abstract][Full Text] [Related]
3. The T1799A BRAF mutation is present in iris melanoma.
Henriquez F; Janssen C; Kemp EG; Roberts F
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4897-900. PubMed ID: 17962436
[TBL] [Abstract][Full Text] [Related]
4. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
[TBL] [Abstract][Full Text] [Related]
5. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
7. [Clinico-echographic diagnostics of iris tumors].
Koch KR; Mor JM; Avgitidou G; Kakkassery V; Rokohl AC; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):313-323. PubMed ID: 30778665
[TBL] [Abstract][Full Text] [Related]
8. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
[TBL] [Abstract][Full Text] [Related]
9. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 mutation profile analysis of head and neck mucosal melanomas: a study of 42 cases.
Öztürk Sari Ş; Yilmaz İ; Taşkin OÇ; Narli G; Şen F; Çomoğlu Ş; Firat P; Bİlgİç B; Yilmazbayhan D; Özlük Y; Büyükbabanİ N
Pathology; 2017 Jan; 49(1):55-61. PubMed ID: 27914687
[TBL] [Abstract][Full Text] [Related]
10. Late Solitary Extraocular Recurrence From Previously Resected Iris Melanoma.
Fabian ID; Thaung C; AlHarby L; Sisley K; Mudhar HS; Doherty RE; Stacey AW; Arora AK; Cohen VML; Sagoo MS
Am J Ophthalmol; 2017 Sep; 181():97-105. PubMed ID: 28673748
[TBL] [Abstract][Full Text] [Related]
11. [New treatment options for iridociliary tumors].
Mor JM; Koch KR; Kakkassery V; Cursiefen C; Heindl LM
Ophthalmologe; 2019 Apr; 116(4):332-339. PubMed ID: 30515574
[TBL] [Abstract][Full Text] [Related]
12. Molecular platforms utilized to detect BRAF V600E mutation in melanoma.
Curry JL; Torres-Cabala CA; Tetzlaff MT; Bowman C; Prieto VG
Semin Cutan Med Surg; 2012 Dec; 31(4):267-73. PubMed ID: 23174497
[TBL] [Abstract][Full Text] [Related]
13. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
[TBL] [Abstract][Full Text] [Related]
14. Validation of an NGS mutation detection panel for melanoma.
Reiman A; Kikuchi H; Scocchia D; Smith P; Tsang YW; Snead D; Cree IA
BMC Cancer; 2017 Feb; 17(1):150. PubMed ID: 28228113
[TBL] [Abstract][Full Text] [Related]
15. Tapioca melanoma of the iris.
de Keizer RJ; Oosterhuis JA; Houtman WA; de Wolff-Rouendaal D
Ann Ophthalmol; 1993 May; 25(5):195-8. PubMed ID: 8517592
[TBL] [Abstract][Full Text] [Related]
16. Optical Coherence Tomography Angiography Characteristics of Iris Melanocytic Tumors.
Skalet AH; Li Y; Lu CD; Jia Y; Lee B; Husvogt L; Maier A; Fujimoto JG; Thomas CR; Huang D
Ophthalmology; 2017 Feb; 124(2):197-204. PubMed ID: 27856029
[TBL] [Abstract][Full Text] [Related]
17. [Clinical signs and differential diagnosis of iris melanoma].
Tóth J
Magy Onkol; 2005; 49(2):153-5, 158-9. PubMed ID: 16249812
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of tumors of the iris and ciliary body].
Liu GQ; Wu ZY; Feng GG; Yang HS; Yan JH; Zheng HL
Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):77-80. PubMed ID: 12783684
[TBL] [Abstract][Full Text] [Related]
19. Mutation analysis of metastatic melanomas in the central nervous system: results of a panel of 5 genes in 48 cases.
Gamsizkan M; Yilmaz I; Simsek HA; Onguru O; Griffin A; Tihan T
Clin Neuropathol; 2016; 35(4):178-85. PubMed ID: 27117140
[TBL] [Abstract][Full Text] [Related]
20. Detection of
Emelyanova M; Ghukasyan L; Abramov I; Ryabaya O; Stepanova E; Kudryavtseva A; Sadritdinova A; Dzhumakova C; Belysheva T; Surzhikov S; Lyubchenko L; Zasedatelev A; Nasedkina T
Oncotarget; 2017 Aug; 8(32):52304-52320. PubMed ID: 28881731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
